Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL475116 | 0.94 | ALOX5 (0.56) | THRATHRBALOX5PTGS2HRH1 | |
| Ethylene Glycol SCHEMBL1798524 | 0.92 | THRA (0.48) | THRATHRBALOX5PTGS2HRH1 | |
| SCHEMBL941553 | 0.92 | THRA (0.58) | THRATHRBALOX5PTGS2LIPG | |
| SCHEMBL3762716 | 0.92 | THRA (0.58) | THRATHRBALOX5PTGS2LIPG | |
| SCHEMBL30432172 | 0.92 | THRA (0.58) | THRATHRBALOX5PTGS2LIPG | |
| SCHEMBL8444310 | 0.92 | THRA (0.58) | THRATHRBALOX5PTGS2LIPG | |
| SCHEMBL173283 | 0.92 | THRA (0.58) | THRATHRBALOX5PTGS2LIPG | |
| SCHEMBL145217 | 0.92 | THRA (0.58) | THRATHRBALOX5PTGS2LIPG | |
| SCHEMBL9505410 | 0.92 | THRA (0.58) | THRATHRBALOX5PTGS2LIPG | |
| SCHEMBL8052297 | 0.92 | THRA (0.58) | THRATHRBALOX5PTGS2LIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1885 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12341054-B2 | Method for fabricating semiconductor device with chelating agent | NANYA TECHNOLOGY CORPORATION (TW) | 2025-06-24 | — | — | US | claimed |
| CN-111269078-B | Condensed-cyclic compound, composition including the same, and organic light-emitting device | 三星显示有限公司 | 2024-07-23 | — | — | CN | claimed |
| CN-117524975-A | Method for manufacturing semiconductor device | 南亚科技股份有限公司 | 2024-02-06 | — | — | CN | claimed |
| US-20230317508-A1 | METHOD FOR FABRICATING SEMICONDUCTOR DEVICE WITH PRE-CLEANING TREATMENT | NANYA TECHNOLOGY CORPORATION (TW) | 2023-10-05 | — | — | US | claimed |
| CN-115108983-B | Preparation method of quinclorac | 定远县嘉禾植物保护剂有限责任公司 | 2023-04-07 | — | — | CN | claimed |
| EP-3323159-B1 | COMPOSITION COMPRISING ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-01-04 | — | — | EP | claimed |
| CN-113912795-B | Polyisomonoolefin copolymer, preparation method thereof, initiator and application | 北京石油化工学院 | 2022-11-22 | — | — | CN | claimed |
| US-11453628-B2 | Condensed cyclic compound, composition including the same, and organic light-emitting device including thin film formed from the composition | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-09-27 | — | — | US | claimed |
| CN-115108983-A | Preparation method of quinclorac | 定远县嘉禾植物保护剂有限责任公司 | 2022-09-27 | — | — | CN | claimed |
| CN-113817366-B | Liquid composition, and method for producing film and laminate using same | ＡＧＣ株式会社 | 2022-08-23 | — | — | CN | claimed |
| WO-2007074226-A1 | LEAD-FREE AVIATION FUEL | TOTAL FRANCE (FR) | 2007-07-05 | — | — | WO | claimed |
| US-20050019655-A1 | An anode of sulfur as active material and ionic liquid electrolyte, e.g. trimethylpropylammonium bistrifluoromethylsulfonimide and lithium bistrifluoromethylsulfonimide; high energy density for portable electronics | SANYO ELECTRIC CO., LTD. (JP) | 2005-01-27 | — | — | US | claimed |
| EP-0798036-B1 | Highly permeable composite reverse osmosis membrane and a reverse osmosis membrane module using the same | NITTO DENKO CORP (JP) | 2003-09-24 | — | — | EP | claimed |
| EP-0718029-B1 | Method for producing highly permeable composite reverse osmosis membrane | NITTO DENKO CORP (JP) | 2003-04-23 | — | — | EP | claimed |
| US-6268512-B1 | HEATING PROPIONYLPHENYLHYDRAZIDE IN PRESENCE OF CALCIUM OXIDE IN SOLVENT TO PRODUCE 3-METHYL-2-OXOINDOLINE | MEDICAL INFORMATION SERVICES, INC. (JP) | 2001-07-31 | — | — | US | claimed |
| EP-1052251-A1 | PROCESS FOR THE PREPARATION OF 3-METHYL-2-OXOINDOLINE | Medical Information Services, Inc. (JP) | 2000-11-15 | — | — | EP | claimed |
| US-5663398-A | Processes for preparing functionalized alkyllithium compounds | FMC CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| US-4929533-A | Using light sensitive diazo resin and high molecular weight copolymer | FUJI PHOTO FILM CO., LTD. (JP) | 1990-05-29 | — | — | US | claimed |
| EP-0108156-B1 | IMPROVED METHOD FOR THE PREPARATION OF NON-CRYSTALLINE POLYMERS OF HIGH MOLECULAR WEIGHT | Conoco Phillips Company (US) | 1989-01-04 | — | — | EP | claimed |
| US-3939242-A | Fabrication process for multiphased plastics | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1976-02-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11453628-B2 | Condensed cyclic compound, composition including the same, and organic light-emitting device including thin film formed from the composition | CRY1, CRY2, NCAPH | THRA 4853/4885THRB 4864/4885ALOX5 993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.